EP-1911: Evaluating the effect of Zinc Oxide nanoparticles doped with Gadolinium on dose enhancement factor  by Banaee, N. et al.
S906                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
3University Hospital Tübingen, Radiation Oncology, Tübingen, 
Germany 
Purpose or Objective: PET/MRI may be highly beneficial for 
radiotherapy planning (RTP) in head and neck (HN) cancer in 
terms of increased accuracy in target volume definition (TVD) 
and integration of functional tissue properties. As the 
integration of imaging data into RTP requires co-registration, 
PET/MR examination in RT treatment position is favorable. 
Therefore, we propose a solution using a dedicated hardware 
setup.  
Moreover, accuracy of TVD depends on the spatial accuracy 
of the imaging data. Since diffusion-weighted MR imaging 
(DWI) based on echo planar imaging (EPI) is prone to spatial 
inaccuracy, the aim of this study was to evaluate the quality 
of DWI with RT scan setup using dedicated distortion 
correction. 
 
Material and Methods: The RT hardware setup consists of a 
flat table overlay and two coil holders for flexible body 
matrix coils (Siemens mMR), in addition to an in-house 
designed overlay add-on for RT mask fixation (cf. Fig1).  
The evaluation of DWI quality using the RT setup was based 
on MR-only scans of n=3 healthy volunteers. Each time, two 
scans were performed: (I) using the RT setup with a pair of 6-
channel flexible RF coils, (II) a reference scan, using a 
standard 16-channel HN coil. The protocol included T2w 
SPACE, T2w TSE, and DWI (b = 150 and 800 s/mm2).  
DWI data was collected with reversed phase encode blips in 
order to use a correction method for susceptibility-induced 
distortions as implemented in the open source toolkit FSL.  
The geometric accuracy of DWI was assessed on a ROI basis 
by comparing pairwise distortion corrected and uncorrected 
b150 images to T2w images. Four ROIs were placed in 
submandibular glands and cervical spine. In addition to 
spatial distances between ROI centers, the Dice similarity 
index (DSI) was calculated to assess ROI similarity.  
Furthermore, ADC values derived from ROIs of the corrected 
b150 images were compared between RT and reference 
scans.  
One set of DW images acquired with RT setup had to be 
excluded from analysis due to strong MR image artifacts. 
 
Results: DWI suffered from geometric distortions with both 
scan setups but correction with FSL led to significantly 
reduced effects. These were of the same order as differences 
in ROI delineation between T2w images due to minor 
involuntary patient motion. The average displacements of the 
ROIs' centers of mass between DW and T2w images were 
4.6±2.3 mm / 5.9±3.4 mm (RT / REF) and 1.0±0.4 mm / 
1.5±0.9 mm for standard DWI and distortion corrected DWI, 
respectively (cf. Fig2 A). Fig2 B presents the average DSI per 
ROI pair: 0.4±0.1 / 0.4±0.2 (RT / REF) and 0.8±0 / 0.7±0.1, 
accordingly.  
ADC values differed by 7±14% on average comparing the RT 
with the standard coil setup. 
 
Conclusion: The presented PET/MR hardware solution for HN 
imaging enables for RT-specific patient positioning. Using 
dedicated correction methods, spatial distortions in DWI can 
be significantly reduced allowing for accurate usage of DWI in 
RTP. ADC values of distortion corrected maps of the RT scan 
setup were found to be adequate. 
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Purpose or Objective: New treatment modalities are 
developed with the aim of escalating tumor absorbed dose 
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and simultaneously sparing the surrounding normal 
structures. Nevertheless, in order to decrease the growth of 
cancerous cells, a high dose of ionizing radiation is needed 
which would generally cause the side effects on healthy 
organs. The use of nanotechnology in cancer treatment offers 
some exciting possibilities including destroying cancer tumors 
with minimal damage to healthy tissues. Zinc Oxide 
nanoparticles (ZnO NPs) are wide band gap semiconductors 
and seem to have a good effect on increasing the absorbed 
dose of target volume especially when doped with a high Z 
element. The aim of this study is to evaluate the effect of 
ZnO NPs doped with Gadolinium on dose enhancement factor 
at different concentrations irradiating by 6MV photon beams.  
 
Material and Methods: In order to study the influence of this 
NP on dose enhancement, PRESAGE dosimeter was fabricated 
by the reported procedure and calibrated against ionization 
chamber, delivering certain levels of absorbed doses. Then 
various concentrations of ZnO NPs and also ZnO NPs doped 
with 5% Gd were incorporated in to PRESAGE composition and 
irradiated by 6 MV photon beams. By using a UV-Vis 
spectrophotometer, optical density changes and also dose 
enhancement factor (DEF) were determined. 
 
Results: Figure 1 shows the color changes of PRESAGE 
containing various concentrations of NPs. 
 
 
 
Fig1. PRESAGE filled cuvettes with and without NPs at dose of 
10Gy. 1) PRESAGE without NPs. 2) PRESAGE with 20µg/ml ZnO 
NPs doped with %5 Gd. 3) PRESAGE with 4000µg/ml ZnO NPs 
doped with %5 Gd. 4) PRESAGE with 4000µg/ml ZnO NPs. 
Table 1 shows DEF acquired by various concentrations of NPs. 
Table 1. DEF of various concentrations of NPs. 
 
 
 
Conclusion: The results of this study revealed that ZnO NPs 
doped with Gd are new proposing substances for enhancing 
the absorbed dose and increasing the therapeutic ratio even 
in high energy photon beams. Various reasons may cause the 
DEF for 6MV photon beams such as photoelectric effect for 
low energy photon beams in continues X-ray spectrum, 
attenuated photons or pair production effect. Using these 
NPs not only reduces the needed MU to deliver a certain 
amount of absorbed dose, but also can lead to great succeeds 
in reducing treatment time. The concentration of NPs has a 
direct relation with DEF. 
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Purpose or Objective: Photodynamic therapy (PDT) is an 
effective treatment modality for specific superficial tumors, 
which uses laser light to activate photosensitizers that have 
been selectively absorbed by tumor cells. However, the finite 
penetration depth of laser light has limited clinical 
applications of PDT. This work investigates the outcomes of 
using Cerenkov light emission from 45MV photon beams on a 
LA45 accelerator to activate photosensitizers for cancer 
therapy. We named this new treatment technique as Radio-
dynamic therapy (RDT). 
 
Material and Methods: Firstly, Monte Carlo simulations were 
utilized to simulate various energies of Cerenkov light and its 
spectroscopy in excited target areas and their efficiency for 
photosensitizer activation. Then, the inner excitation 
efficiency from Cerenkov light in RDT theoretically compared 
with the efficiency of exotic excitation from the external 
laser light in PDT. In addition, we also tested the difference 
of excitation efficiency between a patented catalyst 
coenzyme was added as a substrate and without the 
coenzyme. Next, utilize a specific probe of DMA (Singlet O2 
fluorescent probe-9, 10-dimethylanthracene) to detect 
singlet oxygen. Finally, we also compared our results with 
previous experimental results that reported in previous 
literatures.  
 
Results: Our Monte Carlo results showed that the Cerenkov 
light intensity induced at 45MV photon beams on a LA45 is 8 - 
10 times of the Cerenkov light intensity induced at 6MV beam 
on a conventional accelerator. In RDT, excitation efficiency 
to photosensitizers at 400-450nm peaked wavelength (Soret 
Band) equals 20 times of laser light at 630nm in PDT. The 
homogenous inner excitation in RDT is also about 20 times 
(continuous spectrum excitation and inner scattering) of the 
exotic excitation and exponential attenuation laser light in 
the target of using PDT. Furthermore, the patented catalyst 
coenzyme enhanced the excitation efficiency of 
photosensitizers by 3-6 times under different conditions. In 
clinical situation, the new technique RDT also showed 
favorable outcomes for early and late stage of specific 
cancers and it also good at metastatic cancers treatment. 
 
Conclusion: Our results indicated that the process of using 
the Cerenkov light emission from 45MV photon beams to 
excite photosensitizers has similar process and efficiency as 
conventional laser in PDT. Compared these advantages with 
conventional PDT, RDT may be developed into a potential 
treatment modality for cancer of various stages and other 
diseases.  
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